Cover Image

Dupilumab in Treatment of Chronic Prurigo: A Case Series and Literature Review

Abstract is missing (Short communication)

Saved in:

Bibliographic Details
Main Authors:	Zaid Z. Almustafa (Author), Karsten Weller (Author), Juliane Autenrieth (Author), Marcus Maurer (Author), Martin Metz (Author)
Format:	Book
Published:	Medical Journals Sweden, 2019-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series
by: Luo N, et al.
Published: (2022)

Dupilumab as treatment of actinic prurigo suggests pathophysiologic mechanism of disease: A case series
by: Catherine S. Barker, MD, et al.
Published: (2024)

Dupilumab Significantly Reduces Symptoms of Prurigo Nodularis and Depression: A Case Series
by: Louise Lönndahl, et al.
Published: (2022)

Effective treatment of prurigo nodularis with dupilumab: A case report
by: Chuan Liu, et al.
Published: (2022)

Dupilumab for recalcitrant prurigo nodularis: Case report
by: Joel Reis, et al.
Published: (2022)

Effectiveness of dupilumab for chronic prurigo in elderly patients with atopic dermatitis
by: Shinji Mitsuyama, et al.
Published: (2023)

Simultaneous treatment of Samter triad and prurigo nodularis with dupilumab
by: Joshua D. Bloomstein, BS, et al.
Published: (2021)

Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant
by: Tatevik Ohanyan, et al.
Published: (2017)

Treatment of refractory prurigo nodularis with a monoclonal antibody dupilumab with surprising clinical response
by: Juliana P Alves, et al.
Published: (2023)

A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis
by: Zhixin Zhang, et al.
Published: (2023)

Refractory Kimura's disease accompanied with prurigo responding to dupilumab administration: A case report
by: Fumie Fukami, et al.
Published: (2023)

Maintenance of response to dupilumab in prurigo nodularis: A retrospective cohort study
by: Katina J. Selvaraj, BSc, BA, MD, et al.
Published: (2023)

Refractory bullous pemphigoid with prurigo nodularis successfully treated with dupilumab monotherapy
by: Po-Ta Lai, et al.
Published: (2022)

Recalcitrant prurigo nodularis after COVID‐19 vaccination and successfully treated by dupilumab
by: Shang‐shang Wang, et al.
Published: (2023)

The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series
by: Chen J, et al.
Published: (2023)

The Neuromodulatory Effect of Antipruritic Treatment of Chronic Prurigo
by: Claudia Zeidler, et al.
Published: (2019)

Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect
by: Leore Lavin, MSc, et al.
Published: (2024)

Successful Treatment of Chronic Actinic Dermatitis with Dupilumab: A Case Report and Review of the Literature
by: Chen J, et al.
Published: (2021)

Early-onset, severe prurigo nodularis in a young child with atopic dermatitis treated successfully with dupilumab
by: Henrietta Albela, et al.
Published: (2022)

Prurigo pigmentosa: Case series and differentiation from confluent and reticulated papillomatosis
by: Alina Shevchenko, BS, et al.
Published: (2018)

Prurigo Simplex or "Itchy Red Bump" Disease: Review and Case Series
by: Joanna Wallengren
Published: (2021)

Prolonged hypereosinophilia associated with dupilumab for atopic dermatitis: A case series and review of literature
by: Gabriela Fonseca, BS, et al.
Published: (2024)

[Translated article] Update on Chronic Prurigo
by: A. Docampo-Simón, et al.
Published: (2022)

Comparison between dupilumab and oral Janus kinase inhibitors in the treatment of prurigo nodularis with or without atopic dermatitis in a tertiary care center in Singapore
by: Yik Weng Yew, MBBS, MPH, PhD, et al.
Published: (2023)

Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab
by: Thomas Buttgereit, MD, et al.
Published: (2021)

Treatment-resistant prurigo nodularis
by: Kolli SS, et al.
Published: (2019)

Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
by: Changhua Zhu, MD, et al.
Published: (2023)

Chronic Prurigo: An Unusual Presentation of Hodgkin Lymphoma
by: Shireen Dumont, et al.
Published: (2018)

Chronic Prurigo of Nodular Type: A Review
by: Claudia Zeidler, et al.
Published: (2017)

Recent advances in treatment of prurigo nodularis
by: Chieh-Hsun Chen, et al.
Published: (2024)

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
by: Merav Koschitzky, BA, et al.
Published: (2021)

Analysis of 325 Patients with Chronic Nodular Prurigo: Clinics, Burden of Disease and Course of Treatment
by: Sonja Gründel, et al.
Published: (2020)

Treatment-resistant prurigo nodularis: challenges and solutions
by: Kowalski EH, et al.
Published: (2019)

Prurigo: review of its pathogenesis, diagnosis, and treatment
by: Paulo Ricardo Criado, et al.
Published: (2024)

Association of Chronic Urticaria with Psychological Distress: A Multicentre Cross-sectional Study
by: Samah Tawil, et al.
Published: (2023)

Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and Satisfaction
by: Manuel P. Pereira, et al.
Published: (2021)

Dupilumab in HIV-positive patients: A case series report of 4 patients
by: Ameen Alawadhi, MD, et al.
Published: (2020)

Dupilumab as a novel therapy for management of delusions of parasitosis: A case series
by: Nupur Singh, BA, et al.
Published: (2024)

Tofacitinib for Prurigo Nodularis: A Case Report
by: Peng C, et al.
Published: (2022)

A Case of Prurigo Nodularis Treating by Acupuncture
by: Wu D, et al.
Published: (2021)